A detailed history of Quotient Wealth Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Quotient Wealth Partners, LLC holds 7,782 shares of BMY stock, worth $364,275. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,782
Previous 9,548 18.5%
Holding current value
$364,275
Previous $442 Million 20.6%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 10, 2025

SELL
$43.31 - $48.98 $76,485 - $86,498
-1,766 Reduced 18.5%
7,782 $351 Million
Q2 2025

Jul 29, 2025

SELL
$44.12 - $59.6 $122,168 - $165,032
-2,769 Reduced 22.48%
9,548 $442 Million
Q1 2025

Apr 30, 2025

BUY
$53.9 - $63.11 $197,705 - $231,487
3,668 Added 42.41%
12,317 $751 Million
Q4 2024

Jan 28, 2025

BUY
$51.92 - $59.94 $222,736 - $257,142
4,290 Added 98.42%
8,649 $489 Million
Q3 2024

Oct 09, 2024

BUY
$39.66 - $51.75 $172,877 - $225,578
4,359 New
4,359 $226 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Quotient Wealth Partners, LLC Portfolio

Follow Quotient Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quotient Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quotient Wealth Partners, LLC with notifications on news.